Among other things, the order requires the Food and Drug Administration to increase its reporting of possible shortages of certain prescription drugs, while also speeding up regulatory reviews of new drug manufacturing sites, drug suppliers and manufacturing changes.
Drug manufacturers are being encouraged to voluntarily disclose possible prescription drug shortages in instances not currently required by law.
The total number of prescription drug shortages almost tripled from 2005 to 2010, the White House noted.
Later, White House Press Secretary Jay Carney told reporters the administration will continue to use its executive branch authority to act on a number of fronts without congressional assistance.